Abhilash Perisetti
Hemant Goyal
Neil Sharma- 1Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, United States
- 2The Wright Center for Graduate Medical Education, Scranton, PA, United States
- 3Mercer University School of Medicine, Macon, GA, United States
- 4Division of Interventional Oncology & Surgical Endoscopy (IOSE), Parkview Cancer Institute, Fort Wayne, IN, United States
- 5Indiana University School of Medicine, Fort Wayne, IN, United States
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which led to a worldwide pandemic that started in early 2020. Healthcare systems across the world encountered an unprecedented surge of COVID-19 patients resulting in more than half a million deaths globally. COVID-19 has affected multiple sub-specialties and procedure-related fields, including gastroenterology. Gastrointestinal (GI) endoscopy centers are specialized units where thousands of endoscopies are performed annually. A significant proportion of these procedures are affected due to the national and regional lockdowns across the globe. To adapt to this rapidly evolving situation, endoscopy centers have undergone significant changes and have taken unprecedented precautions to avoid the transmission of the virus. However, endoscopy centers are going through financial strain due to a reduction in the number of procedures from lockdowns and fear of virus transmission. Theoretically, endoscopies could add to the disease transmission as SARS-CoV-2 has shown to be present in the GI secretions. Multiple precautions such as mandatory use of face masks, safe distancing, use of barriers between the endoscopists and patients, negative pressure rooms, extended use of personal protective equipment, and volume reduction have been taken to decrease the risk of disease transmission by these centers. Moreover, pre-endoscopy COVID-19 testing has now become the norm. In this review, we highlight the significant changes assumed by the endoscopy center. Furthermore, we discuss cost-related concerns of pre-endoscopy COVID-19 testing, the downtime and delays related to the procedures, and effects of rescheduling. As the pandemic progresses through multiple phases, endoscopy centers should use a dynamic approach to adapt and strive to provide the best patient care.
Introduction
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Within a few months, it has led to a pandemic of unprecedented levels affecting multiple countries with >16 million cases and >650,000 deaths as of July 26, 2020 (1). The pandemic has caused duress for medical systems and hospitals worldwide. Initially, it was believed that respiratory manifestations dominate the presentation of COVID-19. As the experience with the pandemic evolved, extrapulmonary manifestations are increasingly being recognized (2–6). The Centers for Disease Control and Prevention (CDC) added multiple symptoms as a part of the COVID-19 presentation, which also includes gastrointestinal (GI) manifestations such as nausea, vomiting, dysgeusia, pancreatitis, hepatitis, colitis, etc. (6–10). Additionally, the virus has also been shown to be present in GI secretions. Specialties such as gastroenterology and surgery have been directly affected by COVID-19. This pandemic has had a disruptive effect on the workflow and safety of endoscopists, ancillary staff, and patients. Shortages of personal protective equipment (PPE), lack of testing kits, reduced patient volume, workforce furloughs, and lockdowns have forced these units to be innovative and have them prioritize the high-risk procedures and postpone or even cancel endoscopies in medium- to low-risk cases (11).
Outpatient endoscopy centers usually deal with high-volume and close-contact procedures, which could make them prone to become high-risk COVID-19 transmission areas if extreme precautions are not taken. Millions of colonoscopies are performed as part of the colorectal cancer screening program in the United States (US) (12, 13). A wide variety of other therapeutic endoscopic procedures are also performed on a regular basis (14). Furthermore, the staging and palliation of cancers to aid in managing these lesions are increasingly being performed (15). The COVID-19 pandemic has forced these endoscopy centers to drastically reduce the procedure volume for both elective and semi-urgent cases to reduce transmission risk and preserve PPE (16–19).
Furthermore, there are published data about a decrease in the non-variceal GI bleeding events in line with other disorders such as acute coronary syndrome admissions during the pandemic (20). Although the precise reason for these changes remains speculative, patients may have developed a fear of contracting the infection if they visit the medical centers. Additionally, there is an increased risk of exposure to the virus during outpatient endoscopy procedures due to exposure to GI secretions and respiratory secretions (21, 22). Furthermore, there is a potential for increased generation of infected droplets during coughing, retching, and suctioning, creating aerosolization and increased risk of transmission (23, 24).
Methods
A search for published literature at the time of submission of the manuscript was performed from December 2019 to July 1, 2020. We performed a search of PubMed, Google Scholar, Embase, and Scopus databases to extract articles relevant to endoscopy in COVID-19 patients. The terms “endoscopy,” “gastrointestinal endoscopy,” “staffing,” “barrier protection,” pre-procedure testing,” “COVID-19,” “SARS-CoV-2,” and “coronavirus” were performed. Due to the heterogeneity of the studies, a systemic review could not be performed.
Changes in the Endoscopy Suites
Changes in Endoscopy Suite Structure
Various operational changes have been proposed across endoscopy suits/centers to provide services while mitigating the risk of infection. While these changes depend on several factors (availability of resources locally, infection risk, the demographic profile of the patients, indication and hospital/ endoscopy unit policies), common goals of minimizing the risk of transmission of infection, conserving PPE, and achieving high efficiency remain. To achieve these, Cennamo et al. reported substantial changes in the layout of the endoscopy units with risk-based color-coding of the waiting room, endoscopy suites, and recovery room (25). Additionally, implementations of checkpoints, pathways, and processes based on the color-coding schema were implemented in this study (25). Post-procedure, patients are monitored in the recovery area, with no family available in the waiting room. Hospitals in the US have incorporated policies for not allowing family members, given the risk of exposure and transmission (26). Patients are transported to the hospital entrance to find their respective family member/driver who can further assist in discharge. Results of the procedures are discussed with the patient but are relayed via phone to the authorized person with face-to-face encounters (27). While these changes can potentially contribute to the reduction of endoscopy-related transmission, making it safer for the patients and the staff, they also decrease the in-person relay of information, which is critical at the discharge from the endoscopy units.
Changes in Staffing
COVID-19 first appeared in Wuhan, China, in December 2019. In some areas, the pandemic has overwhelmed the healthcare systems to the point that endoscopy units are potentially treated as COVID-19 units (27, 28). In Brazil, endoscopy staff has been divided into COVID treatment teams and non-COVID endoscopy teams (27). The use of PPE has been mandated by all healthcare systems to minimize the risk of transmission. Prior studies have shown that the use of PPE has not been universal among endoscopists (21, 23). However, with the current pandemic, the use of masks, N-95, gowns, and other PPE has drawn increased attention to avoid spread (24, 29, 30). Endoscopy staff with pre-existing conditions at higher risk of contracting COVID-19 have been assigned non-clinical duties without direct care to COVID-19 patients (27, 28).
Endoscopy staff performing procedures in the operating room should use strict precautions of properly donning and doffing in a separate room prior to entering the operating room. Endoscopy units and operating rooms should follow strict cleaning procedures. Advanced endoscopy procedures such as ERCP frequently need fluoroscopy, equipment trolley, worktable, and anesthesia equipment. The negative pressure rooms are highly recommended in these settings to avoid cross-contamination.
Procedure scheduling during the peak and post-peak has been an area of great challenge for hospitals (31). Increased endoscopy staff furloughs further complicated this challenge (32). Several patient procedures were deferred and put on hold due to decreased slots and uncertainty about when the restrictions will be lifted, and normalcy will be established. Post-procedure telephone follow-ups with patients could be utilized to inquire about developing any new COVID-19 related symptoms to take necessary precautions to individuals who were at potential risk (24, 33). Patients should be informed about the risk of nosocomial infections and also should be informed to report back if they develop any de novo symptoms in the next few days after the procedure.
Change in the Endoscopy Indications
Multiple international societies have recommended restricting endoscopy procedures only to emergent and urgent indications (34). This essential step was taken to minimize the risk of transmission and reduce PPE utilization and use of resources. Studies from multiple countries have shown an endoscopy case-volume median reduction to as high as 99% (19, 35). The impact of COVID-19 varied based on the country, infection rate, initiation of stay-at-home orders, and timing of the pandemic. For example, endoscopy services in the United Kingdom (UK) reduced to 5% in March 2020 after the onset of the pandemic. These changes were noted across all UK regions and endoscopy procedures (36). Procedures were performed only when the benefit outweighs the risk of transmission among the staff.
While the indication for procedures varied, emergent procedures such as active GI bleeding, acute cholangitis, food impactions, and cancer diagnosis/staging/treatment were considered appropriate. A nationwide study in the UK showed that all endoscopic procedures reduced with the pandemic; however, the ERCP activity (performed for emergencies) remains well-preserved (36). Elective procedures, such as screening and surveillance, were deferred. However, the urgent indications of endoscopies remain a gray area based on the endoscopist, institutional guidelines, and available services. Deferring semi-urgent cases could delay the diagnosis of cancers (such as localized pancreatic cancer), and loss of window of therapeutic intervention (endoscopically resectable lesions can become unresectable due to spread). Studies showed that colorectal cancer (CRC) screening declined by 84.5% after the onset of the pandemic in the US (37). Similarly, a 72% reduction in CRC screening was noted in the UK (36). Although multiple GI societies have provided a road map, clinical judgment should prevail, and every case should be individualized with a multidisciplinary team-based approach (38).
Changes in Triaging
Endoscopy staff triage all patients who are undergoing non-urgent endoscopies. In the US, this triaging is done by the pre-procedural COVID-19 testing and a predetermined questionnaire about 2–3 days before the endoscopy date (39, 40). These patients are again triaged by this questionnaire at the time of presentation to the endoscopy suite. The patients are sent to the hospital to seek emergent medical attention in case they have any signs and symptoms of COVID-19 such as cough, shortness of breath, and persistent fever, along with a known history of contact with a COVID-19 patient or travel to high-risk areas (24, 41). Peri-procedural COVID testing involves coordination at multiple levels—contacting patients to undergo testing 24 to 72 h before the procedure and obtaining the results of the test (42). Patients who travel a long distance to get their procedure may cancel their procedure if their COVID-19 testing results are delayed. Also, the absence of family members before, during, and after the procedure can increase anxiety among the patients.
Pre-procedural Testing
COVID-19 testing of all patients before endoscopic procedures may help to identify infected patients and facilitate taking appropriate measures such as isolation precautions, high-risk PPE usage for positive PCR testing, and downtime after the procedure. A thorough analysis of the risks and benefits of widespread pre-procedural testing is needed (Table 1). There are some considerations needed before the development and implementation of the universal testing strategy. Testing for all patients incurs cost burden to the endoscopy units, which can be significant. Additionally, testing may delay procedures if test results are pending, and the possibility of false positivity and false negativity might alter decision-making, which can complicate the processes (1, 43).
Table 1. Pre-procedural universal testing.
Corral et al. reported that PCR testing could be used as an effective strategy to restart endoscopic procedures based on the phase of the pandemic (44). Testing individuals within 48 h of the procedure for semi-elective and elective cases can allow completion of 19.4% (if investing $22 per patient) and 95.3% (if investing $105 per patient) of baseline endoscopies. Implementing this strategy over 1 week in the US will return 165 million US dollars (for 13 million investing) and 767 million US dollars (for 64 million investing) (44). These numbers are promising and demonstrate the potential value of COVID-19 testing for all patients undergoing procedures. Expectedly, this modeling can change with the local prevalence of COVID-19, transmission rate (R0), and accuracy of PCR results. Center for Medicaid and Medicare Services (CMS) and other insurance programs reimburse up to 36 USD to 51 USD per patient (45). These calculations may not apply in areas where testing is not rampant, and reimbursement for endoscopy is low. For example, Sundaram et al. noted that cost of SARS-CoV-2 PCR ($65) might exceed the reimbursement of an upper endoscopy ($30–$60) in countries like India (46). Additionally, the prevalence rate in some of the areas of the country might be too low to test all individuals undergoing endoscopy procedures (46). Testing of high-risk individuals only in specific hot spots is a matter of debate. Furthermore, pre-procedural testing is not uniformly performed in Europe, and the decision is based on the pre-procedure questionnaire. As testing capabilities expand throughout the world, the availability of highly accurate point-of-care testing with rapid results can make this a possibility (47).
Barrier Protection
Safe distancing in the pre-operative area has decreased the number of patients the nursing staff can receive for pre-operative care. It has affected the efficiency of the endoscopy units severely. Only required and critical personnel (endoscopists, nurses, and anesthetists) should be allowed in the endoscopy units (42). Any instrument or device can potentially be a source of infection in aerosol-generating procedures (AGP). Staff should wear PPE as per the local institutional and national guidelines before starting the procedure. Appropriate donning and doffing of the PPE is essential to reduce the risk of infection (27). Belle et al. noted that gastroenterologists who performed procedures on COVID-19 patients have reported symptoms compatible with COVID-19 ranging from 0.6% (3/497 patients) in low prevalence areas compared to 6.1% (12/197) in high prevalence areas (16). Similarly, Chen et al. reported that 5.7% (8/141 patients) reported that gastroenterologists or their colleagues developed work-related COVID-19 infections (17). It led to the development of multiple barrier devices between endoscopists and patients to reduce the risk of exposure to GI secretions (48–53) (Table 2).
Table 2. Barriers to prevent transmission during endoscopy.
Given the inherent nature of the procedures (upper or lower endoscopies), endoscopists are almost always in a “high-transmission zone” (within 3 feet of the patients). Campos et al. introduced a transparent aerosol box (endoprotector) to reduce contact with droplets (49). In this technique, a barrier is used during upper endoscopy, which is made of acrylic plastic to shield the respiratory droplets and potential aerosolization during the procedure (49). A similar barrier is used to decrease the exposure to patients' respiratory droplets during endotracheal intubation (ETI) (50). Traina et al. reported the use of an endoscopic COVID Cube (C-Cube), which is a protective box with access to anesthesiologist's hands and another port for endoscope access (51). Liu et al. reported using a unique disposable device with a combined bite block and oxygen mask for upper GI endoscopic procedures (48). Furthermore, a closed chamber ear, nose, and throat (ENT) examination unit was developed for AGP endoscopic examinations of COVID-19 patients (54). While ETI is usually a one-time event to secure the airway, the use of an endoscope through an endoprotector might make the procedure challenging due to the repeated hand movement of the endoscopists. Nevertheless, the use of these barriers has a significant role in reducing the disease transmission, especially in high-risk or COVID-19 patients.
Endoscopic Transmission
Among the endoscopy procedures, duodenoscopes and echoendoscopes carry a high risk of nosocomial infections (55). While single-use duodenoscopes might be of value in COVID-19-positive patients, they are not universally available and have cost-related constraints (56). Multiple societies have recommended using negative pressure rooms, especially for patients who are suspected of COVID-19 or when the endoscopy is being performed emergently without COVID-19 testing results (30). Intraprocedural changes such as minimal verbal communication, avoiding spill of GI contents via biopsy channel, and avoiding procedures in patients with inadequate bowel preparation should be done (27). Franzini et al. reported the use of a “double gauze technique” where the endoscopists use one gauze and the other by the technician in a controlled fashion to avoid the “whip” effect of accessories and spillage of GI secretions (27). Institutional policies have been developed for minimal personnel to be present for the procedure (57). This is to minimize the risk of exposure among the endoscopy staff. Procedures performed with moderate sedation without the need for anesthesia providers (endoscopist guided sedation) can further minimize the risk of transmission. However, for procedures requiring general anesthesia, societies currently recommend using ETI to reduce the risk of aerosolization with suspected or confirmed COVID-19 (58).
Enhanced cleaning procedures have been implemented by most endoscopy units (24). Strict adherence to local and national policies should be followed while cleaning the endoscopy suites (59). This includes cleaning all horizontal surfaces, frequently touched surfaces with particular emphasis on areas within a few feet of the patient. Multiple studies showed that SARS-CoV-2 can involve any segment of the GI tract. Intestinal autopsy in COVID-19 patients showed stenosis and dilatation of the small intestine (60). Mucosal damage was noted in multiple areas such as esophagus, stomach, duodenum, colon, and rectum (61, 62). Endoscopic procedures, due to their inherent nature of coming in contact with GI secretions, could potentially get contaminated with virus. Although there is a theoretical risk of endoscopes acting as potential vectors for viral infections, so far, there is no published report of SARS-CoV-2 transmission via endoscopes (39). Nevertheless, the reprocessing process should include high-level disinfection (HLD). Traditionally, testing for leakage is performed before washing of the endoscope. However, suggestions have been made for performing this after washing the endoscope. Whether this can affect the proper functioning of the scope remains to be studied (48).
Procedural Downtime
Patients undergoing endoscopy have the potential risk of aerosol generation. All rooms after the procedure should be deemed contaminated after the procedure. During the induction of anesthesia, only essential personnel for securing the airway should be present, which requires endoscopy staff to wait outside the procedure room. After completing the endoscopic procedure, the endoscopist and non-essential staff should exit the room before extubating the patient.
The time needed to allow for dispersion of the virus-laden aerosols to clear will depend on the rate of air changes/hour (ACH). If a rate of 25–30 cycles/hour is used, 3 min are needed to wait before a procedure could be started after intubation. The precise time needed for closure of the room depends on the use of negative pressure and air-exchange rate (63). While this is dependent on transmission dynamics, multiple other factors such as air-exchange rate, duration of aerosolized droplets suspended in the air, viral load in the droplets, the viability of the virus (can be up to 3 h), and environmental contamination could play a role (Table 3).
Table 3. Factors* predicting downtime between endoscopic procedures.
A cautious approach is recommended until further data emerge (19). Per the CDC (63), airborne contaminant removal is dependent on ACH and duration, which determines the efficiency of removal. For example, a room with a minimum ACH of 12–15 cycles per hour, at a duration of 28 min to 35 min, is needed to achieve a contaminant removal efficiency of 99.9% (63). This efficiency comes down if the ACH is low and if viral contamination in the air is high. Societies have recommended adequately ventilated rooms (with at least 12 ACH and controlled direction of airflow with mechanical ventilation should be used). For rooms without negative pressure capability, a minimum of 60 min delay (downtime) is recommended compared to 30-min downtime for negative pressure room (24).
Endoscopy Trainee Involvement
Endoscopy trainees' (gastroenterology fellows and surgery residents) involvement in GI procedures have been affected significantly during the pandemic (64, 65). A multinational survey study spanning 63 countries reported a reduction of endoscopy volume by up to 93.8%, with colonoscopy being affected the most, which is a core endoscopy skill (35). Furthermore, an increased degree of anxiety and burnout were noted among endoscopists. This concern not only was restricted to trainees but also affected entire endoscopy staff for the risk of acquiring COVID-19, especially after the resumption of elective endoscopies (66). However, in areas with low risk of infection transmission, trainees continue to be involved in the procedures.
During the initial phase of the pandemic, most endoscopy units implemented policies to have only essential fully trained staff to avoid exposure and reduce the turnover time (30). Multiple survey studies have demonstrated adverse effects on endoscopy training and an unexpectedly significant fear and anxiety during pandemic (35, 67, 68). Multiple GI and surgical societies have increased the availability of electronic resources to fill this gap in the training (69, 70). Additionally, programs have implemented various mechanisms to mitigate the loss of procedure volume with video recording, simulation labs, and increasing involvement in low-risk procedures.
Future Outlook of Endoscopy Units
In the future, endoscopy units will likely incorporate some of the changes during the pandemic for increased safety of the patients and endoscopy staff. It remains speculative to predict the end of this pandemic, but localized outbreaks may continue to occur even when we see a pandemic downtrend (71). Important questions remain open if endoscopy staff and patients should continue to be screened and tested regularly. It is only presumptive to say about the effect of cancer burden due to delayed screening, surveillance, and handling the increased backlog cases. Multiple strategies can be adopted to decrease or ease endoscopy demand. Patients who are eligible for the screening should be provided with options of CRC screening, including stool-based testing, which do not need patients to present to the healthcare facilities. Home-based stool testing has the advantage of testing without contact with hospitals or clinics (72). For patients who test positive, there is a significant risk of advanced adenomas on the endoscopy, and hence a triage system should be developed to prioritize the procedures (72). Because of these, there will be increased demand in the recovery phase that likely needs to be phased appropriately to avoid significant waiting times for procedures that need to happen in a timely fashion. It involves careful evaluation of patient demographics (comorbidities) and environmental factors (staff availability, local resources, community spread, and infection rate) (73). As the recovery phase starts, the real effect on the delay in cancer screening will emerge.
Patients should be communicated about the importance of screenings in the recovery phase to avoid delays and to keep the appointments. There should be an effective use of electronic health record communication strategies to provide updates to patients about COVID-19-related changes in endoscopy units. Virtual tools such as increased telehealth visits to discuss and engage patients about cancer screening programs will increase the endoscopy show rates (74). A triage system to review all the posted case by qualified medical personnel and reschedule the procedures in a tiered fashion can make this process less stressful (42). Furthermore, endoscopy staff should communicate with schedulers about the patient's concerns, which can be directly addressed. Finally, a higher threshold should be adopted for endoscopy procedures, which will less likely change the outcomes in patients (75). Despite these changes, as this pandemic unfolds with localized outbreaks, endoscopy units remain at a threat of temporary closures and need for enhanced disinfection protocols. Preparing for future pandemics should be a part of the operation of the endoscopy units' stress response. Nevertheless, endoscopy units should continue to adapt and navigate to provide high-quality patient care with equal emphasis on patient and staff safety.
Limitations
Due to the rapidly evolving nature of the COVID-19 pandemic, endoscopy units continue to adapt, and the above recommendation can change. Due to the heterogeneity of the published literature, we could not perform a systematic review. Pre-procedural testing, triaging, and trainee involvement in the procedures are dependent on infection risk, local endoscopy unit, and hospital policies. As countries are starting the recovery phase of the COVID-19 pandemic, these measures are constantly being updated.
Conclusion
Endoscopy units are on the verge of significant changes and evolution with the unfolding of the COVID-19 pandemic. The current pandemic calls for multiple changes at different levels not only to perform procedures in a safe environment for patients but also to prevent infection to the endoscopy staff. It appears likely that COVID-19 will be an integral part of our lives, like other viruses such as influenza. Similar to other procedures' predominant specialties, endoscopy units are incorporating operational changes in order to provide care in these unprecedented times. The use of enhanced protocols with particular emphasis on assessing the risk status of the patient, proper use of PPE, and perioperative procedural changes incorporated during this pandemic should be a lesson for the future. While some of these changes can gain permanent stance in the future, adapting to the future outbreaks is critical to provide excellent care.
Author Contributions
HG and AP: conception and design and literature review. AP: first draft. All authors: critical revision, editing, and final approval. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Worldometer July 4th. Coronavirus Update (Live): 11,287,104 Cases and 530,935 Deaths from COVID-19 Virus Pandemic - Worldometer. (2020). Available online at: https://www.worldometers.info/coronavirus/#countries
2. Perisetti A, Gajendran M, Goyal H. Putative mechanisms of diarrhea in COVID-19. Clin Gastroenterol Hepatol. (2020) 3565:30780-1. doi: 10.1016/j.cgh.2020.06.008
3. Ramachandran P, Onukogu I, Ghanta S, Gajendran M, Perisetti A, Goyal H, et al. Gastrointestinal Symptoms and outcomes in hospitalized COVID-19 patients. Dig Dis. (2020) 38:373–9. doi: 10.1159/000509774
4. Gadiparthi C, Perisetti A, Sayana H, Tharian B, Inamdar S, Korman A. Gastrointestinal bleeding in patients with severe SARS-CoV-2. Am J Gastroenterol. (2020) 115:1283–5. doi: 10.14309/ajg.0000000000000719
5. Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased serum aminotransferase activity and clinical outcomes in coronavirus disease 2019. J Clin Exp Hepatol. (2020) doi: 10.1016/j.jceh.2020.06.009. [Epub ahead of print].
6. Johnson KD, Harris C, Cain J, Hummer C, Goyal H, Perisetti A. Pulmonary and extra-pulmonary clinical manifestations of COVID-19. Front Med. (2020) 7:526. doi: 10.3389/fmed.2020.00526
7. CDC. Added Symptoms of Coronavirus. CDC: @CDCgov (2020). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
8. Sultan S, Altayar O, Siddique S, Davitkov P, Feuerstein J, Lim J, et al. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. (2020) 159:320–34. doi: 10.1053/j.gastro.2020.05.001
9. Aloysius M, Thatti A, Gupta A. COVID-19 presenting as acute pancreatitis. Pancreatology. (2020) 20:1026–7. doi: 10.1016/j.pan.2020.05.003
10. Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. (2020) 65:1932–9. doi: 10.1007/s10620-020-06362-8
11. Parasa S, Reddy N, Faigel D, Repici A, Emura F, Sharma P. Global impact of the COVID-19 pandemic on endoscopy: an international survey of 252 centers from 55 countries. Gastroenterology. (2020) 159:1579–81.e5. doi: 10.1053/j.gastro.2020.06.009
12. Dorsey YC, Roper J. Utility of surveillance and screening colonoscopy in older adults. Gastroenterology. (2020) 159:795–7. doi: 10.1053/j.gastro.2020.06.036
13. Perisetti A, Khan H, George NE, Yendala R, Rafiq A, Blakely S, et al. Colorectal cancer screening use among insured adults: is out-of-pocket cost a barrier to routine screening? World J Gastrointest Pharmacol Ther. (2018) 9:31. doi: 10.4292/wjgpt.v9.i4.31
14. Research i. An Astounding 19 Million Colonoscopies are Performed Annually in The United States. (2018). Available online at: https://idataresearch.com/an-astounding-19-million-colonoscopies-are-performed-annually-in-the-united-states/ (accessed August 08, 2018).
15. Fisher DA, Shergill AK, Early DS, Acosta RD, Chandrasekhara V, Chathadi KV, et al. Role of endoscopy in the staging and management of colorectal cancer. Gastrointest Endosc. (2013) 78:8–12. doi: 10.1016/j.gie.2013.04.163
16. Belle A, Barret M, Bernardini D, Tarrerias A-L, Bories E, Costil V, et al. Impact of the COVID-19 pandemic on the gastrointestinal endoscopic activity in France. Endoscopy. (2020) doi: 10.1055/a-1201-9618. [Epub ahead of print].
17. Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, et al. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res. (2020) doi: 10.5217/ir.2020.00037. [Epub ahead of print].
18. Forbes N, Smith ZL, Spitzer RL, Keswani RN, Wani SB, Elmunzer BJ, et al. Changes in gastroenterology and endoscopy practices in response to the covid-19 pandemic: results from a North American survey. Gastroenterology. (2020) 159:772–4. doi: 10.1053/j.gastro.2020.04.071
19. Repici A, Pace F, Gabbiadini R, Colombo M, Hassan C, Dinelli M. Endoscopy units and the coronavirus disease 2019 outbreak: a multicenter experience from Italy. Gastroenterology. (2020) 159:363–6. doi: 10.1053/j.gastro.2020.04.003
20. Schmiderer A, Schwaighofer H, Niederreiter L, Profanter C, Steinle H, Ziachehabi A, et al. Decline in acute upper gastrointestinal bleeding during Covid-19 pandemic after lockdown in Austria. Endoscopy. (2020) 52:1036–38. doi: 10.1055/a-1178-4656
21. Johnston ER, Habib-Bein N, Dueker JM, Quiroz B, Corsaro E, Ambrogio M, et al. Risk of bacterial exposure to the endoscopist's face during endoscopy. Gastrointest Endosc. (2019) 89:818–24. doi: 10.1016/j.gie.2018.10.034
22. Tian Y, Rong L, Nian W, He Y. gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. (2020) 51:843–51. doi: 10.1111/apt.15731
23. Perisetti A, Garg S, Inamdar S, Tharian B. Role of face mask in preventing bacterial exposure to the endoscopist's face. Gastrointest Endosc. (2019) 90:859. doi: 10.1016/j.gie.2019.06.016
24. Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc. (2020) 92:192–7. doi: 10.1016/j.gie.2020.03.019
25. Cennamo V, Bassi M, Landi S, Apolito P, Ghersi S, Dabizzi E, et al. Redesign of a GI endoscopy unit during the COVID-19 emergency: a practical model. Dig Liver Dis. (2020) 52:1178–87. doi: 10.1016/j.dld.2020.05.007
26. Matsos S. Visitor Guidelines. Johns Hopkins Medicine (2020). Available online at: https://www.hopkinsmedicine.org/coronavirus/visitor-guidelines.html
27. Franzini TAP, Kotinda APST, Moura DTHd, Badana MLV, Medeiros MSd, Lima PGR, et al. Approach to endoscopic procedures: a routine protocol from a quaternary university referral center exclusively for coronavirus disease 2019 patients. Clinics. (2020) 75:e1989. doi: 10.6061/clinics/2020/e1989
28. Maida M, Sferrazza S, Savarino E, Ricciardiello L, Repici A, Morisco F, et al. Impact of the COVID-19 pandemic on gastroenterology divisions in Italy: a national survey. Dig Liver Dis. (2020) 52:808–15. doi: 10.1016/j.dld.2020.05.017
29. Boškoski I, Gallo C, Wallace MB, Costamagna G. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse. Gastrointest Endosc. (2020) 92:519–23. doi: 10.1016/j.gie.2020.04.048
30. Gralnek IM, Hassan C, Beilenhoff U, Antonelli G, Ebigbo A, Pellisè M, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. (2020) 52:483–90. doi: 10.1055/a-1155-6229
31. Guda NM, Emura F, Reddy DN, Rey JF, Seo DW, Gyokeres T, et al. Recommendations for the operation of endoscopy centers in the setting of the COVID19 pandemic–A WEO guidance document. Dig Endosc. (2020) doi: 10.1111/den.13777. [Epub ahead of print].
32. Amato A, Rondonotti E, Radaelli F. Lay-off of endoscopy services for the COVID-19 pandemic: how can we resume the practice of routine cases? Gastroenterology. (2020). doi: 10.1053/j.gastro.2020.04.049. [Epub a head of print].
33. Repici A, Aragona G, Cengia G, Cantù P, Spadaccini M, Maselli R, et al. Low risk of covid-19 transmission in GI endoscopy. Gut. (2020) 69:1925–7. doi: 10.1136/gutjnl-2020-321341
34. Philip M, Lakhtakia S, Aggarwal R, Madan K, Saraswat V, Makharia G. Joint guidance from SGEI, ISG and INASL for gastroenterologists and gastrointestinal endoscopists on the prevention, care, and management of patients with COVID-19. J Clin Exp Hepatol. (2020) 10:266–70. doi: 10.1016/j.jceh.2020.04.001
35. Pawlak KM, Kral J, Khan R, Amin S, Bilal M, Lui RN, et al. Impact of COVID-19 on endoscopy trainees: an international survey. Gastrointest Endosc. (2020) 92:925–35. doi: 10.1016/j.gie.2020.06.010
36. Rutter MD, Brookes M, Lee TJ, Rogers P, Sharp L. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a national endoscopy database analysis. Gut. (2020) doi: 10.1136/gutjnl-2020-322179. [Epub ahead of print].
37. London JW, Fazio-Eynullayeva E, Palchuk MB, Sankey P, McNair C. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Inform. (2020) 4:657–65. doi: 10.1200/CCI.20.00068
38. Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, et al. COVID-19 epidemic: proposed alternatives in the management of digestive cancers: a French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. (2020) 52:597–603. doi: 10.1016/j.dld.2020.03.031
39. Perisetti A, Gajendran M, Boregowda U, Bansal P, Goyal H. COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies. Dig Endosc. (2020) 32:715–22. doi: 10.1111/den.13693
40. Sawhney M, Bilal M, Pohl H, Kushnir V, Khashab M, Schulman A, et al. Triaging advanced GI endoscopy procedures during the COVID-19 pandemic: consensus recommendations using the delphi method. Gastrointest Endosc. (2020) 92:535–42. doi: 10.1016/j.gie.2020.05.014
41. Aziz M, Perisetti A, Lee-Smith W, Gajendran M, Bansal P, Goyal H. Taste changes (Dysgeusia) in COVID-19: a systematic review and metaanalysis. Gastroenterology. (2020) 159:1132–3. doi: 10.1053/j.gastro.2020.05.003
42. Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, et al. AGA Institute rapid recommendations for gastrointestinal procedures during the COVID-19 pandemic. Gastroenterology. (2020) 159:739–58. doi: 10.1053/j.gastro.2020.03.072
43. Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. (2020) 20:453–4. doi: 10.1080/14737159.2020.1757437
44. Corral JE, Hoogenboom SA, Kröner PT, Vazquez-Roque MI, Picco MF, Farraye FA, et al. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis. Gastrointest Endosc. (2020) 92:524–34. doi: 10.1016/j.gie.2020.04.049
45. Medicare. Medicare Reimbursement for COVID-19 Tests Will Be About $36 for the CDC Test and $51 for Those Created in House or by Other Entities. @RevCycleIntel (2020). Available online at: https://revcycleintelligence.com/news/cms-releases-medicare-reimbursement-details-for-covid-19-tests (accessed March 16, 2020).
46. Sundaram S. COVID-19 testing before every endoscopy: is india ready for prime time? Gastrointest Endosc. (2020) 92:789–91. doi: 10.1016/j.gie.2020.05.012
47. Thompson CC, Shen L, Lee LS. COVID-19 in endoscopy: time to do more? Gastrointest Endosc. (2020) 92:435–9. doi: 10.1016/j.gie.2020.03.3848
48. Liu X, Cai M, Shi Q, Wang P, Zhou P. Shanghai zhongshan experience on digestive endoscopic procedures during 2020 COVID-19 pandemic. Am J Gastroenterol. (2020) 115:805–8. doi: 10.14309/ajg.0000000000000680
49. Campos S, Carreira C, Marques PP, Vieira A. Endoprotector: protective box for safe endoscopy use during COVID-19 outbreak. Endosc Int Open. (2020) 8:E817–21. doi: 10.1055/a-1180-8527
50. Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med. (2020) 382:1957–8. doi: 10.1056/NEJMc2007589
51. Traina M, Amata M, Granata A, Ligresti D, Gaetano B. The C-Cube: an endoscopic solution in the time of COVID-19. Endoscopy. (2020) 52:E351–2. doi: 10.1055/a-1190-3462
52. Onoyama T, Fuji M, Isomoto H. The useful face-protective shield “ORIGAMI” for gastrointestinal endoscopy during the COVID-19 pandemic. Dig Endosc. (2020) 24:10.1111/den.13780. doi: 10.1111/den.13780
53. Sagami R, Nishikiori H, Sato T, Murakami K. Endoscopic shield: barrier enclosure during the endoscopy to prevent aerosol droplets during the COVID-19 pandemic. VideoGIE. (2020) 5:445–8. doi: 10.1016/j.vgie.2020.05.002
54. Sayin I, Devecioglu I, Yazici ZM. A closed chamber ENT examination unit for aerosol-generating endoscopic examinations of COVID-19 patients. Ear Nose Throat J. (2020) 99:594–6. doi: 10.1177/0145561320931216
55. Rahman MR, Perisetti A, Coman R, Bansal P, Chhabra R, Goyal H. Duodenoscope-associated infections: update on an emerging problem. Dig Dis Sci. (2019) 64:1409–18. doi: 10.1007/s10620-018-5431-7
56. Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. (2019) 19:2108–17. doi: 10.1016/j.cgh.2019.10.052
57. Smith ZL, Das KK, Kushnir VM. Anesthesia-administered sedation for endoscopic retrograde cholangiopancreatography: monitored anesthesia care or general endotracheal anesthesia? Curr Opin Anesthesiol. (2019) 32:531–7. doi: 10.1097/ACO.0000000000000741
58. Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li J, et al. Perioperative management of patients infected with the novel coronavirusrecommendation from the joint task force of the chinese society of anesthesiology and the chinese association of anesthesiologists. Anesthesiology. (2020) 132:1307–16. doi: 10.1097/ALN.0000000000003301
59. Gu Q, Wang H, Fang Y, Lu Y, Shen Z, Wang Y, et al. Analysis of an improved workflow of endoscope reprocessing for bedside endoscopic diagnosis and treatment on COVID-19 patients. J Zhejiang Univ SciB. (2020) 21:416–22. doi: 10.1631/jzus.B2000109
60. Ma C, Cong Y, Zhang H. COVID-19 and the digestive system. Am J Gastroenterol. (2020) 115:1003–6. doi: 10.14309/ajg.0000000000000691
61. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. (2020) 158:1831–3.e3. doi: 10.1053/j.gastro.2020.02.055
62. Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, et al. SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Am J Gastroenterol. (2020) 115:942–6. doi: 10.14309/ajg.0000000000000667
63. CDC. Air Changes/Hour (ACH) and Time Required for Airborne-Contaminant Removal by Efficiency. (2019). Available online at: https://www.cdc.gov/infectioncontrol/guidelines/environmental/appendix/air.html
64. Shah R, Satyavada S, Ismail M, Kurin M, Smith ZL, Cooper GS, et al. COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining. Gastrointest Endosc. (2020) 92:394–8. doi: 10.1016/j.gie.2020.03.3852
65. Goyal H, Gajendran M, Boregowda U, Perisetti A, Aziz M, Bansal P, et al. Current and future implications of COVID-19 on gastroenterology training and clinical practice. Int J Clin Pract. (2020) e13717. doi: 10.1111/ijcp.13717. [Epub ahead of print].
66. Rex D, Vemulapalli K, Lahr R, McHenry L, Sherman S, Al-Haddad M. Endoscopy staff are concerned about acquiring COVID-19 infection when resuming elective endoscopy. Gastroenterology. (2020) 159:1167–9. doi: 10.1053/j.gastro.2020.05.038
67. Mallon D, Pohl JF, Phatak UP, Fernandes M, Rosen JM, Lusman SS, et al. Impact of COVID-19 on pediatric gastroenterology fellow training in North America. J Pediatric Gastroenterol Nutr. (2020) 71:6–11. doi: 10.1097/MPG.0000000000002768
68. Roemmele C, Manzeneder J, Messmann H, Ebigbo A. Impact of the COVID-19 outbreak on endoscopy training in a tertiary care centre in Germany. Frontline Gastroenterol. (2020) 11:454–7. doi: 10.1136/flgastro-2020-101504
69. AGA. Gastroenterology Professional Society Guidance on Endoscopic Procedures During the COVID-19 Pandemic. (2020). Available online at: https://www.asge.org/home/advanced-education-training/covid-19-asge-updates-for-members/
gastroenterology-professional-society-guidance-on-endoscopic-procedures-during-the-covid-19-pandemic
70. ASGE. American Society for Gastrointestinal Endoscopy: guidance for trainees during the COVID-19 pandemic. Gastrointest Endosc. (2020) 92:748–53. doi: 10.1016/j.gie.2020.05.032
71. Hayee BH, Thoufeeq M, Rees CJ, Penman I, East J. Safely restarting GI endoscopy in the era of COVID-19. Gut. (2020) 69:2063–70. doi: 10.1136/gutjnl-2020-321688
72. Săftoiu A, Hassan C, Areia M, Bhutani MS, Bisschops R, Bories E, et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. (2020) 52:293–304. doi: 10.1055/a-1104-5245
73. Machicado JD, Papachristou GI, Cote GA, Wani S, Groce JR, Conwell DL, et al. Pancreaticobiliary endoscopy in the COVID-19 pandemic era. Pancreas. (2020) 49:729–32. doi: 10.1097/MPA.0000000000001580
74. Webster P. Virtual health care in the era of COVID-19. Lancet. (2020) 395:1180–1. doi: 10.1016/S0140-6736(20)30818-7
Keywords: coronavirus, coronavirus (2019-nCoV), SARS-CoV-2 infection, pandemic (COVID-19), endoscopy, gastrointestinal disease, fellowship and training
Citation: Perisetti A, Goyal H and Sharma N (2020) Gastrointestinal Endoscopy in the Era of COVID-19. Front. Med. 7:587602. doi: 10.3389/fmed.2020.587602
Received: 26 July 2020; Accepted: 09 October 2020;
Published: 26 November 2020.
Edited by:
Hu Zhang, Sichuan University, ChinaCopyright © 2020 Perisetti, Goyal and Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hemant Goyal, doc.hemant@yahoo.com